Home » Topics » BioWorld Science

BioWorld Science
RSS

Bacterial toxins weaken gut barrier

Dec. 20, 2018

Less is more for durable STING effects

Dec. 20, 2018

Lilly begins phase III study of tirzepatide in patients with type 2 diabetes and cardiovascular risk

Dec. 20, 2018

HAL Allergy begins first-in-human study of HAL-MRE1 in ragweed allergic patients

Dec. 20, 2018

Spheroid-based xenograft model better mimics pancreatic ductile adenocarcinoma

Dec. 20, 2018

BiTE expression by oncolytic virus for targeted killing of cancer cells and associated fibroblasts

Dec. 20, 2018

LB-100 shows preclinical efficacy against lapatinib-resistant HER2-positive breast cancer models

Dec. 20, 2018

BPX-601 well tolerated in first-in-human study in advanced solid tumors

Dec. 20, 2018

EZH2 as a novel therapeutic target for restoration of MHC expression in DLBCL

Dec. 20, 2018

European Commission approves Dengvaxia for prevention of dengue

Dec. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...